Date(s) - Friday, June 4, 2021
Time - 9:30 am - 11:30 am

Insurance Challenges in the Current & Emerging NJ Medicinal and Adult-Use Marijuana Programs

Please join the ICNJ’s Virtual Spring Workshop to learn about the obstacles and opportunities in NJ’s marijuana programs, including patient access, affordability, reimbursement, commercial liability and the legal landscape.

Medical Marijuana

In 2012, NJ began its Medical Marijuana Program (MMP) and has since expanded through increased eligibility, amount, delivery and access. In turn, there are over 100,000 patients enrolled in the MMP and with that an increase in litigation and reimbursement disputes. The New Jersey Supreme Court recently issued a decision in Hager v. M&K Construction ordering the defendant employer to reimburse the workers’ compensation claimant for marijuana that was prescribed to relieve his back pain caused by a work injury. This decision highlights the financial obstacles facing patients as cannabis remains an FDA Schedule I drug and an out-of-pocket expense. In spite of Federal action to ease the liability and concerns of states, financial institutions and insurers, there is reluctance to directly reimburse patients for MMP care. This panel will review the impact of Hager, how NJ’s court decisions compare to other states and how a new approach is on the horizon to address these costs through the creation of a dispensary-patient-employer benefits network.


Legalization of Adult-Use Marijuana

With NJ embarking on the establishment of an adult-use cannabis marketplace and issuing seven classes of licenses (lab testing, cultivator, manufacturer, wholesaler, distributor, retailer & delivery), what insurance products can new growers/dispensaries/wholesalers etc. expect in NJ? How are insurance products evolving to provide coverage for these businesses, including workers’ compensation for their employees? What is the experience of permitted operators in NJ’s Medicinal Marijuana Program and do new insurance issues emerge as the state transitions to the adult-use market? This panel will explain the expanding commercial general liability insurance products and the necessity for additional endorsements and new classifications to address the cannabis industry’s business and legal needs.


Confirmed Panelists: 

                               Rita Barone,   Esq., Partner,   Flanagan, Barone & O’Brien, LLC

                  Joseph Lam, Senior Director of Commercial Multi-Peril Product Development,    Verisk Analytics

                           Don Parisi,   President,   Bennabis   Health












  • NJ Dept. of Banking & Insurance Continuing Education Credits for Producers 2 credits (pending)
  • AICPCU/IIA Continuing Professional Development Points for CPCUs – 2 credits (pending)
  • New Jersey Continuing Legal Education Credits for Certified Attorneys – 2.4 credits (pending)
  • New York Continuing Legal Education Credits for Certified Attorneys – 2.4 credits (pending)

Sponsorship of this event is available here


For scholarship information or questions contact Mary Novak.


No refunds or cancellations after May 28, 2021.


This will be a virtual meeting using the Zoom platform. You will receive a confirmation of your registration immediately and then about a week before the event watch for a link with login credentials to join the day of the event.


Register Now

Bookings are closed for this event.